CE vs TVTX · rev $10.28B vs rev $233.2M
Celanese Corporation (CE) versus Travere Therapeutics Inc (TVTX) — a side-by-side from cached financials, not a winner call.
Celanese Corporation (CE) is a chemicals company listed on US.
Travere Therapeutics Inc (TVTX) is a biotechnology company listed on US.
Latest reported CE revenue for 2024-12-31 was $10.28B. Net income was -$1.51B. Revenue was down 6.0% from 2023-12-31 to 2024-12-31. CE currently screens at market cap $5.92B.
Latest reported TVTX revenue for 2024-12-31 was $233.2M. Net income was -$321.5M. Revenue was up 417.5% from 2023-12-31 to 2024-12-31. TVTX currently screens at market cap $1.33B.
CE currently screens at market cap $5.92B. TVTX currently screens at market cap $1.33B.
Not investment advice. Open the CE and TVTX stock pages for the full models.
Not investment advice.